CASE IS OPEN AND READY.
54 yrs old male. HISTORY: progressing pancytopenia. Primary aspirate: up to 19% blasts. BLOOD: WBC (*10e9/l) 2,02 ; NEU (*10e9/l) 0,21; RBC (*10e12/l) 2,72; HgB (g/l) 90; Plt (x10e9/l) 75. ASPIRATE (now): Blasts 26,0%; Erythropoiesis expanded, normoblastic, dyserythropoietic; Granulopoiesis: diminished, hypogranulated, irregularly segmented. HISTO: Massivelly effaced architecture with prominent atypical erthroid hyperplasia/dysplasia (with giant nuclei)up to 40% visually, immature myeloid precursors up to 25%, dysplastic megakaryopoiesis. IH: CD34+ infiltration absent; CD117+ precursors up to 25% (peritrabecular and interstitial); CD123+ single cells; TdT+ single cells; HLA-DR+ population up to 15%; ATYPICAL ERYTHROID: p53 (+/+++) 100%; GlycophorinC (++/+++)100%. Megas vWF+. FLOW: Blastic population ~ 16 % nucleated cells (moderate caliber). IH: CD45+ weak, CD34+, CD38+, CD71+ weak, CD117+, HLA-DR+, CD13+ dim, CD33+, cMPO+ weak, CD11b-, CD14-, CD15-, CD56-, CD64-. Blasts- of MYELOID genenesis. Signs of dysgranulopoiesis, irregular CD11b/CD13/CD16 expression. VISUALISATION: Aperio (username guest, if required). MOLECS: No known abnormalities was present (PML/RARA t(15;17)(q22;q21); AML1/ETO t(8;21)(q22;q22); CBFB/MYH11 inv(16)(p13;q22); CEBPA; FLT3 ITD; NPM1; DEK/NUP214 t(6;9)(p23;q34)). PROPOSAL: AML, M6 (?) at least 25% BM space (visible myeloid precursors), probably associated with MDS/RCMD. CONTRA: By flow and in aspirate erythrokaryocytic population not exceeds 50%. Thankyoualot Annotations
»
Add comment
(Login)
|
Last modified: 2013-06-29 12:41:04